Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash Flows From Operating Activities    
Net loss $ (14,943) $ (26,451)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 5,374 5,501
Interest accretion expense 496 549
Bad debt (recovery) expense (140) 585
Reversal of 2019 bonus accrual (1,156)
Mark to market on warrants 50 (61)
Amortization of deferred financing fees 122
Accrued interest - note payable 120
Note payable fees 312
Stock-based compensation 1,255 2,187
ESPP expense 113 55
Change in fair value of note payable (58)
Deferred income taxes 38 37
Loss on DiamiR transaction 13
Change in fair value of contingent consideration (338) (489)
Asset impairment 37
Other gains and expenses, net (2)
Other changes in operating assets and liabilities:    
Decrease in accounts receivable 2,148 1,725
Decrease in other current assets 28 241
Increase in other long-term assets (118)
Decrease in accounts payable (1,817) (198)
(Decrease) increase in accrued salaries and bonus (137) 1,976
(Decrease) increase in accrued liabilities (1,086) 1,395
(Decrease) increase in long-term liabilities (149) 88
Net cash used in operating activities (8,719) (13,979)
Cash Flows From Investing Activity    
Purchase of property and equipment (354) (1,575)
Sale of property and equipment 39
Net cash used in investing activities (315) (1,575)
Cash Flows From Financing Activities    
Issuance of common stock, net of expenses 335 434
Issuance of Series B preferred stock, net of expenses 19,223
Loan proceeds - related parties 7,500
Loan proceeds - BroadOak 8,000
Loan expenses - BroadOak (312)
Payment of related party note and related interest (7,924)
Financing fees - related party (123)
Borrowings (payments) on Line of Credit 1,500 (3,000)
Cash paid for repurchase of restricted shares (52)
Net cash provided by financing activities 8,976 16,605
Net (decrease) increase in cash, cash equivalents and restricted cash (58) 1,051
Cash, cash equivalents and restricted cash – beginning 3,372 2,321
Cash, cash equivalents and restricted cash – ending $ 3,314 $ 3,372